These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33831377)

  • 1. Transforming lives through genetics.
    Cell; 2021 Apr; 184(8):1953-1955. PubMed ID: 33831377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Szent-Györgyi Prize for Progress in Cancer Research: basic and translational research recognition : Mary-Claire King received the 2016 Prize for her pioneering research that demonstrated the first evidence of genetic predisposition to breast cancer.
    Hartmann H; Zhao J; Ba S
    Chin J Cancer; 2017 Nov; 36(1):92. PubMed ID: 29162161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioneering geneticist Mary-Claire King receives the 2014 Lasker~Koshland Special Achievement Award in Medical Science.
    Hurst JH
    J Clin Invest; 2014 Oct; 124(10):4148-51. PubMed ID: 25196046
    [No Abstract]   [Full Text] [Related]  

  • 4. Connecting communities to tackle cancer from many sides.
    Cell; 2021 Apr; 184(8):1949-1952. PubMed ID: 33831376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasker Award winner Mary-Claire King.
    King MC
    Nat Med; 2014 Oct; 20(10):1124-5. PubMed ID: 25295950
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of breast and ovarian cancer.
    Narod SA
    Br Med Bull; 1994 Jul; 50(3):656-76. PubMed ID: 7987646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asking the Question of Why.
    Cell; 2020 Apr; 181(3):503-506. PubMed ID: 32234522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bringing research to the intensive care setting.
    Cell; 2022 Apr; 185(8):1275-1278. PubMed ID: 35385690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer and ovarian cancer genetics.
    Edlich RF; Winters KL; Lin KY
    J Long Term Eff Med Implants; 2005; 15(5):533-45. PubMed ID: 16218901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving as a Scientist and a Mentor.
    Cell; 2019 Apr; 177(3):510-513. PubMed ID: 30952444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2020 William Allan Award introduction: Mary-Claire King.
    Eichler EE
    Am J Hum Genet; 2021 Mar; 108(3):383-385. PubMed ID: 33667390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of Mary-Claire King, 2014 Lasker-Koshland Special Achievement in Medical Science awardee.
    Chakravarti A
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17690-2. PubMed ID: 25425662
    [No Abstract]   [Full Text] [Related]  

  • 13. Lasker∼Koshland to genetics pioneer.
    Botstein D
    Cell; 2014 Sep; 158(6):1230-1232. PubMed ID: 25215481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 Mutations in Breast and Ovarian Cancer.
    Silwal-Pandit L; Langerød A; Børresen-Dale AL
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27815305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?
    Vineyard MA; Daniels MS; Urbauer DL; Deavers MT; Sun CC; Boerwinkle E; Bodurka DC; Gershenson DM; Crawford J; Lu KH
    Gynecol Oncol; 2011 Feb; 120(2):229-32. PubMed ID: 21126756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.
    Prucka SK; McIlvried DE; Korf BR
    Med Princ Pract; 2008; 17(3):173-89. PubMed ID: 18408385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study: Mary is a healthy 33-year-old woman concerned about her risk of breast cancer.
    Weber BL; Watson P; Stefanek ME; Wells NL; Helzlsouer KJ
    Cancer Pract; 1994; 2(4):252-5. PubMed ID: 7858651
    [No Abstract]   [Full Text] [Related]  

  • 18. The current social, political, and medical role of genetic testing in familial breast and ovarian carcinomas.
    Weitzel JN
    Curr Opin Obstet Gynecol; 1999 Feb; 11(1):65-70. PubMed ID: 10047966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S; Ansley K; Delaney SD; Ramkissoon S
    Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of primary breast cancer of the vulva with hereditary breast and ovarian cancer.
    Lamb A; Darus CJ; Skripenova S; Weisberg T; Miesfeldt S
    J Clin Oncol; 2013 May; 31(13):e231-2. PubMed ID: 23530107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.